Our work involves the identification and characterisation of genes that play a role in the development, maintenance and function of the retina and includes both visual and non-image forming tasks.
\n \n\n \n \nOur research interests range across the neurosciences but with specific interests in circadian, visual and behavioural neuroscience.
\n \n\n \n \nOur research focuses on the non-image forming function of the eye, including how the light environment regulates sleep and circadian rhythms and how these responses are affected in disease.
\n \n\n \n \nThe discovery of a novel inner retinal photoreceptor cell, driving non-visual functions, has had a significant impact on the retinal neuroscience field. My research focuses on understanding the physiology and function of these photosensitive retinal ganglion cells.
\n \n\n \n \nWe develop techniques and hardware on the Centre\u2019s 7 Tesla MRI scanner to offer neuroscientists exciting new possibilities to image the structure, function and biochemistry of the human brain.
\n \n\n \n \nThe Oxford Respiratory Group works collaboratively on a range of projects dedicated to Respiratory Control. Professor Pandit's group studies anaesthetic effects on oxygen sensing and also focusses on clinical research related to effects of anaesthetics on respiration and anaesthetic techniques on the lungs and airway.
\n \n\n \n \nWorld-leading ALS/MND research group
\n \n\n \n \nNeuromyelitis optica (NMO) is a rare disease causing inflammation in the spinal cord and optic nerves. The NMO service brings together expertise in diagnostics and clinical management to improve outcomes for this often isolated group of patients.
\n \n\n \n \nNeuroplastics is a collaborative network of three research groups at OxCIN with a shared interest in brain plasticity. We study how the brain changes when we learn, as we get older, or when we recover from damage such as stroke. We use brain imaging to monitor brain change and we aim to develop new approaches to facilitate learning, recovery and healthy ageing.
\n \n\n \n \nWe study how the brain changes when we learn, as we get older, or when we recover damage such as stroke. We use brain imaging to monitor brain change and we aim to develop new approaches to facilitate learning, recovery and healthy brain development and ageing.
\n \n\n \n \nWe are collaborating with clinical colleagues to develop novel MRI acquisition and analysis methods that address the wide spectrum of cerebrovascular disease.
\n \n\n \n \nFMRIB\u2019s Neurodegeneration group comprises clinical and basic neuroscientists across a range of departments and disciplines with a common interest in using neuroimaging to understand normal ageing and disease processes.
\n \n\n \n \nWe investigate anatomical organisation and cortical processing using computational models and techniques.
\n \n\n \n \nWe develop image acquisition and reconstruction techniques for functional MRI. These methods aim to provide higher spatial and temporal resolution, as well as greater sensitivity to brain activity.
\n \n\n \n \nThe fine-scale structure of brain tissue is crucial to neural function and health. We are developing MRI techniques that may enable non-invasive estimates of brain microstructure.
\n \n\n \n \nWe develop new ways to measure metabolically active chemicals with MRI in order to understand the dynamic chemistry of the human brain. Our particular interests are in \"multi-voxel\" or spectroscopic imaging, and measuring dynamically changing processes. We create new MR techniques and publish software to do this.
\n \n\n \n \n